Biden puts taxing the rich back in the spotlight
It's an idea championed by US President Joe Biden, leading economists and even the IMF -- make the rich pay more taxes to replenish public coffers and narrow huge wealth gaps
Clot questions over J&J and AstraZeneca vaccines
The European Medicines Agency (EMA) says blood clots should be listed as a "very rare" side effect of the Johnson & Johnson COVID vaccine. What we know about the jab and similar AstraZeneca shot:
Pandemic hits ‘critical point’ as Europe deaths top one million
Europe has passed the grim milestone of one million coronavirus deaths, as the WHO warned that infections are rising exponentially despite widespread efforts aimed at stopping them
AstraZeneca vaccine: what we know and what we don’t
A European Medicines Agency recommendation that a type of blood clot should be listed as a "very rare side effect" of the AstraZeneca jab stopped just short of saying there is a causal link with the vaccine
AstraZeneca: Who is using the jab, and who isn’t
The AstraZeneca vaccine's rollercoaster ride has taken another twist with a growing list of countries restricting its use over "very rare" blood clots
Questions about AstraZeneca jab linger
Fears of what is causing the 'highly untypical' blood clots seen in some people vaccinated against Covid-19 have undermined confidence in the AstraZeneca vaccine
Europe badly lags US in jabs-in-arms race
The World Health Organization has rebuked Europe for its its sluggish Covid vaccine rollout and an AFP tally shows the continent is badly lagging behind in the jabs-in-arms race
At EU’s Moldova-Romania frontier, pandemic lays bare inequality
So far, non-EU member Moldova has received barely enough vaccine doses for three percent of its population, while Romania, an EU member since 2007, has administered almost three million
Pandemic upsurge hits Europe recovery hopes
An upsurge in new coronavirus cases is forcing governments across Europe into new, damaging lockdowns that threaten to delay a much hoped-for return to growth, economists say
EU vaccine export-vetting scheme: 5 things to know
The European Commission has toughened up its Covid-19 vaccine export vetting scheme. Here are the five main things to know about the "transparency and authorisation mechanism"